Health News

Rx May Offer Hope for Some Non-Hodgkin Lymphoma Patients
Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.
Colon Condition Linked to Cardiovascular Disease
Diverticulosis — the presence of small pockets in the walls of the colon — is a very common digestive condition among older people. Researchers recently explored if diverticular diseases raised risks for cardiovascular disease.
Non-Hodgkin Lymphoma Rx Reduced Tumors
A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.
Using Genetic Engineering to Treat Cancer
Many leukemias can be treated successfully, but if the disease doesn’t respond, patients are left with few options. A new therapy may change all that.
It Took Two to Fight Lymphoma
Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.
Reducing Discomfort of Leukemia Treatment
While leukemia treatments can be uncomfortable, they also save lives. Still, reducing the discomfort of these treatments remains important, especially for the youngest patients.
Not Too Old for a Stem Cell Transplant
Age can impact a patient’s treatment options, but when it comes to stem cell transplants, a recent study showed that being old may not be something to be worry about.
Blood Clot Risks Found for Hospitalized Children
Venous thromboembolism (VTE) is rare in children, which often causes it to be overlooked, leading to delays in treatment that can sometimes be deadly.
Study Finds Promising Treatment for Myelofibrosis
Myelofibrosis is a type of chronic leukemia that attacks bone marrow. Researchers at Mayo Clinic showed promising study results for one treatment for this disease.
Banned Rx May Save Young Lives
A medication taken off the market in 2010 may have a new use in treating children with an aggressive form of blood cancer.